611 participants
A Combination of Acalabrutinib With R-CHOP in Subjects With Previously Untreated Non-GCB DLBCL (ACE-LY-312)
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-06-25
- Start Date:
- 2020-10-08
- Completion:
- 2027-02-22
Conditions
- Diffuse Large B-Cell Lymphoma
Interventions
- DRUG
No Results Yet